David Fletcher

5.6k total citations
143 papers, 3.4k citations indexed

About

David Fletcher is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, David Fletcher has authored 143 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 36 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in David Fletcher's work include Neuropeptides and Animal Physiology (22 papers), Gallbladder and Bile Duct Disorders (22 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). David Fletcher is often cited by papers focused on Neuropeptides and Animal Physiology (22 papers), Gallbladder and Bile Duct Disorders (22 papers) and Pediatric Hepatobiliary Diseases and Treatments (12 papers). David Fletcher collaborates with scholars based in Australia, United States and United Kingdom. David Fletcher's co-authors include Mary B. Mazanec, Charlotte S. Kaetzel, John G. Nedrud, Matthew Knuiman, K. J. Hardy, M. E. Lamm, Arthur Shulkes, Liora Valinsky, Michael Hobbs and C. D’Arcy J. Holman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

David Fletcher

137 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Fletcher Australia 28 1.4k 1.3k 607 490 413 143 3.4k
Peter Armstrong United States 40 2.4k 1.7× 1.1k 0.8× 288 0.5× 590 1.2× 143 0.3× 152 5.8k
Stephen J. Roth United States 30 1.0k 0.8× 849 0.7× 516 0.9× 1.4k 2.8× 870 2.1× 106 4.4k
William F. McNeely United States 19 887 0.7× 842 0.6× 311 0.5× 573 1.2× 168 0.4× 378 3.4k
Robert B. Love United States 37 2.6k 1.9× 912 0.7× 368 0.6× 693 1.4× 535 1.3× 114 4.2k
David Price United Kingdom 26 619 0.5× 317 0.2× 431 0.7× 950 1.9× 207 0.5× 106 2.9k
W. Jean Dodds United States 30 1.4k 1.0× 995 0.8× 198 0.3× 286 0.6× 220 0.5× 157 3.4k
Luis R. Espinoza United States 45 1.2k 0.9× 928 0.7× 323 0.5× 1.0k 2.1× 1.9k 4.7× 269 7.2k
Claire Langston United States 39 1.7k 1.3× 2.5k 1.9× 402 0.7× 667 1.4× 177 0.4× 127 5.1k
Hiroshi Takahashi Japan 38 1.9k 1.4× 355 0.3× 612 1.0× 815 1.7× 498 1.2× 276 5.9k
Vincenzo Esposito Italy 33 516 0.4× 765 0.6× 1.1k 1.9× 410 0.8× 163 0.4× 147 3.6k

Countries citing papers authored by David Fletcher

Since Specialization
Citations

This map shows the geographic impact of David Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fletcher more than expected).

Fields of papers citing papers by David Fletcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fletcher. The network helps show where David Fletcher may publish in the future.

Co-authorship network of co-authors of David Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of David Fletcher. A scholar is included among the top collaborators of David Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fletcher. David Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fletcher, David, et al.. (2025). Sacrococcygeal Pilonidal Sinus Disease: A Decade‐In‐Review of Patient‐Reported Outcome Measures. ANZ Journal of Surgery. 96(3). 525–536.
2.
Isali, Ilaha, Phillip McClellan, David Fletcher, et al.. (2024). Differential effects of macrophage subtype‐specific cytokines on fibroblast proliferation and endothelial cell function in co‐culture system. Journal of Biomedical Materials Research Part A. 113(1). e37799–e37799. 3 indexed citations
3.
Smith, Sarah, Adeel Khoja, Joshua G. Kovoor, et al.. (2022). Mesh versus non‐mesh repair of groin hernias: a rapid review. ANZ Journal of Surgery. 92(10). 2492–2499. 5 indexed citations
4.
Bonfield, Tracey L., et al.. (2021). Donor-Defined Mesenchymal Stem Cell Antimicrobial Potency Against Nontuberculous Mycobacterium. Stem Cells Translational Medicine. 10(8). 1202–1216. 15 indexed citations
5.
Heeckeren, Anna M. van, et al.. (2021). Enhancing Cystic Fibrosis Immune Regulation. Frontiers in Pharmacology. 12. 573065–573065. 14 indexed citations
6.
Fletcher, David, et al.. (2021). Transportation System Resilience: Research Roadmap and White Papers. Transportation Research Board eBooks. 1 indexed citations
7.
Smith, Graham, Colin Kovacs, Jason Brunetta, et al.. (2020). Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral Regimens. AIDS Research and Human Retroviruses. 37(1). 44–53. 1 indexed citations
9.
10.
Smith, Graham, Jason Brunetta, Mona Loutfy, et al.. (2012). Etravirine with 2 NRTIs: an effective switch option for ARV simplification and side effect management. Journal of the International AIDS Society. 15(S4). 1–1. 1 indexed citations
11.
Antoniou, Tony, J. Raboud, Shuhang Shen, et al.. (2007). Risk Factors for Grade 3–4 Liver Enzyme Elevation in HIV and Hepatitis C Coinfected Patients on Combination Antiretroviral Therapy. AIDS Patient Care and STDs. 21(7). 469–478. 9 indexed citations
12.
Jaff, Michael R., James Hermiller, Charles A. Simonton, et al.. (2006). The safety and efficacy of the StarClose® vascular closure system: The ultrasound substudy of the CLIP study. Catheterization and Cardiovascular Interventions. 68(5). 684–689. 32 indexed citations
13.
Ramsay, Duncan, Swithin Song, Simon Edmunds, et al.. (2004). Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium‐enhanced magnetic resonance imaging. Australasian Radiology. 48(2). 154–161. 45 indexed citations
14.
Triantafyllou, Asterios, David Fletcher, & John Scott. (2004). Glycosylations in demilunar and central acinar cells of the submandibular salivary gland of ferret investigated by lectin histochemistry. Archives of Oral Biology. 49(9). 697–703. 10 indexed citations
15.
Barwood, Nigel, Liora Valinsky, Michael Hobbs, et al.. (2002). Changing Methods of Imaging the Common Bile Duct in the Laparoscopic Cholecystectomy Era in Western Australia. Annals of Surgery. 235(1). 41–50. 32 indexed citations
16.
Fletcher, David. (1995). Operative Cholangiogram at Laparoscopic Cholecystectomy. Surgical Innovation. 2(2). 111–117. 4 indexed citations
17.
Fletcher, David, et al.. (1993). THE MORBIDITY OF SURGICAL ACCESS: A STUDY OF OPEN VERSUS LAPAROSCOPIC CHOLECYSTECTOMY. Australian and New Zealand Journal of Surgery. 63(12). 952–954. 4 indexed citations
18.
Fletcher, David, et al.. (1992). Laparoscopic cholecystectomy for complicated gallstone disease. Surgical Endoscopy. 6(4). 179–182. 17 indexed citations
19.
Jones, Robert, et al.. (1991). LAPAROSCOPIC CHOLECYSTECTOMY INITIAL EXPERIENCE. Australian and New Zealand Journal of Surgery. 61(4). 261–266. 32 indexed citations
20.
Fletcher, David, et al.. (1987). THE VAGUS AND NEUROTENSIN RELEASE IN DUODENAL ULCER—CLINICAL AND EXPERIMENTAL STUDIES. Australian and New Zealand Journal of Surgery. 57(9). 661–665. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026